If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Corporate Update

14 Sep 2009 07:00

RNS Number : 9502Y
Tarsus Group PLC
14 September 2009
 



14 September 2009

Tarsus Group plc

Corporate Update

Tarsus Group plc ('Tarsus' or 'the Group' or 'the Company'), the international business-to-business media group, is pleased to announce the following corporate update for the period since the announcement of its record interim results on 29th July 2009..

France

The Group has disposed of its 50% shareholding in MD Management SAS to its joint venture partner, Reed Exhibitions France, for a net cash consideration of £ 0.4 million. 

This transaction has resulted in a small book profit and continues the strategy of rationalising the Group's portfolio to focus on larger events, with established brands, which tend to be more resilient throughout the economic cycle.

China

Tarsus has entered into an agreement with its joint venture partner Hubei Hope to invest together a further RMB 10 million (approximately £ 0.9 million) of cash into their joint venture, Tarsus Hope.

The monies will be used to fund acquisitions and new launches in the joint venture's core exhibition sectors of medical equipment and industrial equipment in Central China. The investment is conditional on Chinese regulatory approval, but marks a further step in the development of the Group's portfolio of events in one of the fastest growing exhibition markets in the world.

Trading

The Group's second half exhibitions have begun well, with the Off-Price Show in Las Vegas in August and the Medical event in San Jose in September both now currently trading slightly ahead of management's previous expectations.

Importantly, revenues for the two largest exhibitions in Tarsus' portfolio, Labelexpo Europe in September and the Dubai Airshow in November, continue to remain comfortably ahead of the comparable events in 2007. 

Douglas Emslie, Group Managing Director, said:

"We continue to execute against our strategy of increasing our business in the faster growing emerging markets while actively managing our portfolio in our mature markets.

 Trading for the Group for the full year continues to be in line with the Board's expectations and we anticipate a very satisfactory outcome for 2009."

For further information please contact:

Tarsus Group plc

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

Media

Matthew Moth, Madano Partnership 020 7593 4000

Investor Relations

Neville Harris, IR Focus 020 7593 4015

Stephen ScottJeremy Wiseman, Scott Harris 020 7653 0030

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLBMITMMTBBLL
Date   Source Headline
16th May 20197:00 amRNSTrading Update
9th May 20196:19 pmRNSBlock Listing Six Monthly Return
30th Apr 201910:14 amRNSTotal Voting Rights
16th Apr 20192:40 pmRNSDirector/PDMR Shareholding
2nd Apr 20193:43 pmRNSBlock listing Interim Review
1st Apr 201910:44 amRNSTotal Voting Rights
19th Mar 201911:42 amRNS2018 Annual Report
8th Mar 20194:36 pmRNSPrice Monitoring Extension
27th Feb 20197:00 amRNSFinal Results
6th Feb 20194:35 pmRNSPrice Monitoring Extension
31st Jan 201911:53 amRNSTotal Voting Rights
30th Jan 20197:00 amRNSOption agreement re Tarsus Connect
16th Jan 20194:22 pmRNSApplication for Admission
14th Jan 20197:00 amRNSYear-end Trading Update
13th Dec 20184:48 pmRNSScrip Dividend Circular (the "Circular")
30th Nov 20183:10 pmRNSTotal Voting Rights
20th Nov 20181:44 pmRNSApplication for Admission
6th Nov 20187:00 amRNSCapital Markets Seminar and Trading Update
1st Nov 20182:56 pmRNSTotal Voting Rights
18th Sep 20186:20 pmRNSDirector/PDMR Shareholding
14th Sep 201812:06 pmRNSResults of Placing
14th Sep 20187:00 amRNSAcquisitions and Placing of New Ordinary Shares
10th Sep 20183:18 pmRNSBlock Listing Six Monthly Return
31st Aug 20183:39 pmRNSTotal Voting Rights
24th Aug 201811:17 amRNSHalf-year Report
1st Aug 201811:54 amRNSTotal Voting Rights
26th Jul 20187:00 amRNSHalf-year Report
13th Jul 20182:34 pmRNSApplication for Admission - scrip dividend shares
13th Jul 20182:18 pmRNSDirector Declaration
21st Jun 20181:52 pmRNSResult of AGM
18th Jun 20183:37 pmRNSHolding(s) in Company
12th Jun 20184:41 pmRNSDirector/PDMR Shareholding
8th Jun 20183:45 pmRNSScrip Dividend Circular
1st Jun 201812:31 pmRNSTotal Voting Rights
21st May 20186:10 pmRNSNotice of AGM
17th May 20187:00 amRNSTrading Update
9th May 20187:00 amRNSBlock Listing Six Monthly Return
9th May 20187:00 amRNSBoard Changes
1st May 201811:45 amRNSTotal Voting Rights and Capital
20th Apr 201812:15 pmRNSDirector/PDMR Shareholding
20th Apr 201812:14 pmRNSDirector/PDMR Shareholding
18th Apr 20184:29 pmRNSNotification of Transactions
29th Mar 201810:50 amRNSTotal Voting Rights
22nd Mar 20185:01 pmRNS2017 Annual Report
9th Mar 20183:54 pmRNSDirector/PDMR Shareholding
6th Mar 201810:18 amRNSBlock Listing Six Monthly Return
5th Mar 20185:06 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSFinal Results
31st Jan 20189:40 amRNSTotal Voting Rights
12th Jan 201810:30 amRNSApplication for Admission - scrip dividend shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.